Definitive Healthcare Corp. (NASDAQ:DH) Receives Average Recommendation of “Hold” from Brokerages

Shares of Definitive Healthcare Corp. (NASDAQ:DH) have been given a consensus rating of “Hold” by the eleven brokerages that are presently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation and three have issued a buy recommendation on the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $5.81.

DH has been the topic of several research analyst reports. Deutsche Bank Aktiengesellschaft lowered their target price on shares of Definitive Healthcare from $7.00 to $5.00 and set a “hold” rating on the stock in a report on Friday, August 9th. BTIG Research began coverage on shares of Definitive Healthcare in a report on Tuesday, September 17th. They issued a “buy” rating and a $7.00 target price on the stock. Robert W. Baird decreased their price target on shares of Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 7th. Needham & Company LLC reaffirmed a “hold” rating on shares of Definitive Healthcare in a research note on Friday, November 8th. Finally, Barclays decreased their price target on shares of Definitive Healthcare from $6.00 to $4.00 and set an “equal weight” rating on the stock in a research note on Wednesday, August 7th.

Definitive Healthcare Price Performance

DH stock opened at $4.52 on Friday. Definitive Healthcare has a one year low of $3.19 and a one year high of $10.62. The company’s fifty day moving average price is $4.36 and its 200-day moving average price is $4.95. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.40 and a current ratio of 2.49. The company has a market capitalization of $522.15 million, a PE ratio of -1.46, a price-to-earnings-growth ratio of 6.67 and a beta of 1.33.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of DH. Norden Group LLC bought a new position in Definitive Healthcare during the first quarter valued at $83,000. Oppenheimer Asset Management Inc. grew its holdings in shares of Definitive Healthcare by 40.5% in the first quarter. Oppenheimer Asset Management Inc. now owns 49,393 shares of the company’s stock worth $399,000 after purchasing an additional 14,229 shares during the last quarter. Swiss National Bank grew its holdings in shares of Definitive Healthcare by 2.9% in the first quarter. Swiss National Bank now owns 103,300 shares of the company’s stock worth $834,000 after purchasing an additional 2,900 shares during the last quarter. Susquehanna Fundamental Investments LLC bought a new position in shares of Definitive Healthcare in the first quarter worth about $120,000. Finally, Vanguard Group Inc. grew its holdings in shares of Definitive Healthcare by 1.5% in the first quarter. Vanguard Group Inc. now owns 4,535,377 shares of the company’s stock worth $36,600,000 after purchasing an additional 67,068 shares during the last quarter. Institutional investors own 98.67% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.